不眠症の急性治療のためのカンナビノール ランダム化プラセボ制御クロスオーバー試験
Isobel G Lavender1,2,3, Nathaniel S Marshall1,4, Danielle McCartney1,2,3
1Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, Macquarie University, Sydney, New South Wales, Australia.
Journal of sleep research
|February 16, 2026
まとめ
カンナビノールは,不眠症の成人の睡眠開始を有意に改善したり,覚醒を軽減したりしませんでした. しかし,300mgの投与量は睡眠の質を向上させ,睡眠の覚醒を減少させた.
科学分野:
- スリープ・メディシン (睡眠医学)
- 薬理学 薬理学とは
背景:
- 不眠症は健康に重大な影響を及ぼし,革新的な治療戦略を必要とします.
- カンナビノール (CBN) は,Δ9-テトラヒドロカンナビノールの誘導体であり,催眠効果があると逸話的に報告されているが,睡眠と不眠に対する客観的な影響は未確認のままである.
研究 の 目的:
- 不眠障害の治療としてカンナビノール (CBN) の急性有効性と安全性を調査する.
- ポリソムノグラフィで測定された客観的な睡眠パラメータに対するカナビノールの単回経口投与の影響を評価する.
主な方法:
- ランダム化,ダブルブラインド,プラセボ対照,三組の,一夜間のクロスオーバー試験が行われました.
- 不眠症と診断された20人の成人は,30mgまたは300mgのカンナビノールまたはプラセボを投与されました.
- 主なアウトカムとして,睡眠開始後の目覚め (WASO) を測定するために,夜間ポリソムノグラフィが使用されました.
主要な成果:
- カンナビノールは,不眠症の患者にWASOを有意に変化させなかった.
- カンナビノールの300mgの投与量は,非急速眼球運動2睡眠と主観的な睡眠品質を著しく改善しました.
- 睡眠開始の遅延および電気脳図覚醒指数の有意な減少は,300mgの投与量で観察されました.
結論:
- カナビノールの単一投与は,不眠症の成人の客観的な睡眠継続性を有意に改善しませんでした.
- カナビノールの高用量は,睡眠の質を向上させ,睡眠障害を軽減する潜在的利点を示した.
- 大規模で長期にわたる試験によるさらなる研究は,不眠症に対するカンナビノールの治療の可能性を完全に確認するために推奨されます.
関連する概念動画
01:19Management of Insomnia
688
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
688
01:27Insomnia
507
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
507
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
804
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
804
01:24Substance Use Disorders Affecting Sleep
463
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
463
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
633
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
633
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.4K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.4K